Wegovy and Ozempic, both forms of semaglutide, are used for different medical conditions but come at similar costs. Typically, these medications are priced at:
Wegovy is specifically approved for weight loss in people with obesity or those who are overweight with related health conditions, whereas Ozempic is primarily approved for managing Type 2 diabetes. Both drugs reduce appetite and slow stomach emptying, helping to lower food intake. Clinical evidence indicates that both medications are effective for weight loss, but Wegovy, being tailored for weight management, may be more appropriate for individuals primarily focused on losing weight.
Wegovy is not recommended for individuals who:
Similar to Wegovy, Ozempic should be avoided by individuals with:
Ozempic is specifically approved for managing Type 2 diabetes and should not be used solely for weight loss unless prescribed off-label by a healthcare provider.
Both Wegovy and Ozempic can cause similar side effects, which may include:
These gastrointestinal issues are the most common side effects and typically decrease over time as the body adjusts to the medication.
The benefits of using Wegovy and Ozempic include:
Insurance coverage for Wegovy and Ozempic can vary widely. Many insurance plans cover these medications, especially if they are prescribed for their approved uses:
Patients should check with their insurance provider to determine coverage specifics, co-pays, and any required prior authorizations.
According to FDA guidelines, Wegovy is intended for:
The FDA has also approved Wegovy for use in children and teens aged 12 and older who are dealing with obesity.
Ozempic is FDA-approved for people with Type 2 diabetes to help control blood sugar levels and assist with weight loss as a secondary benefit.
Yes, Wegovy and Ozempic are both formulations of semaglutide. However, they are marketed under different names and prescribed in different doses for distinct medical purposes:
Both medications mimic a hormone called glucagon-like peptide-1 (GLP-1), which targets brain regions that regulate appetite. By decreasing appetite and slowing stomach emptying, these drugs help individuals feel fuller longer, reducing their food intake.
In the U.S., approximately 70% of adults are obese or overweight, leading to higher risks for serious health conditions such as heart disease, stroke, diabetes, and certain cancers. Achieving a weight loss of 5% to 10% can significantly reduce these risks. Medications like Wegovy and Ozempic provide effective tools to help individuals achieve and maintain a healthier weight.
For patients without insurance coverage or seeking additional payment options, we offer self-pay packages designed to fit your budget. Our goal is to make Wegovy or Ozempic injections affordable and accessible to all individuals committed to achieving their weight loss goals.
Both Wegovy and Ozempic are available at competitive prices:
Dr. Terushkin offers both Wegovy and Ozempic at these rates, making these treatments accessible for those seeking medical assistance in weight management or diabetes control.
At the Goal BMI Clinic, we believe in providing personalized care and support to every patient. From your initial consultation to ongoing follow-up appointments, Dr. Sergey Terushkin and our dedicated team will be with you every step of the way, helping you achieve and maintain your weight loss goals.
Contact the Goal BMI Clinic today to learn more about Wegovy or Ozempic injections and start your journey towards a healthier, happier you.
At GoalBMI – General And Bariatric Surgery in Brooklyn, NY, we combine advanced surgical care with a personalized, patient-first approach.
Every treatment plan is designed around you — your health, your goals, and your long-term success. We use modern, minimally invasive techniques to deliver safe outcomes, faster recovery, and real results.
Common procedures include laparoscopic gastric banding, sleeve gastrectomy, gallbladder surgery, and hernia repair — all performed with precision and care.
